542 results on '"Pocchiari, Maurizio"'
Search Results
2. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
3. The importance of ongoing international surveillance for Creutzfeldt–Jakob disease
4. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study
5. Genome wide association study of clinical duration and age at onset of sporadic CJD
6. MRI abnormalities in Creutzfeldt–Jakob disease and other rapidly progressive dementia
7. Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
8. Ultra-High-Pressure Inactivation of Prion Infectivity in Processed Meat: A Practical Method to Prevent Human Infection
9. High-Pressure Inactivation of Transmissible Spongiform Encephalopathy Agents (Prions) in Processed Meats
10. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene
11. Concluding remarks
12. Preface
13. Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier
14. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels
15. Biochemical and Neuropathological Findings in a Creutzfeldt–Jakob Disease Patient with the Rare Val180Ile-129Val Haplotype in the Prion Protein Gene
16. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
17. Detection and Diagnosis of Prion Diseases Using RT-QuIC: An Update
18. Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type)
19. Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples
20. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
21. High-Pressure Inactivation of Transmissible Spongiform Encephalopathy Agents (Prions) in Processed Meats
22. Amyloidogenesis in Transmissible Spongiform Encephalopathies
23. Prevalence of variant CJD in the UK
24. Problems in the Evaluation of Theoretical Risks for Humans to Become Infected with BSE-Contaminated Bovine-Derived Pharmaceutical Products
25. Effect of Amphotericin B on Different Experimental Strains of Spongiform Encephalopathy Agents
26. The pathological prion protein forms ionic conductance in lipid bilayer
27. Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease
28. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease
29. Supplement to: A test for Creutzfeldt-Jakob disease using nasal brushings.
30. Possible Implications of the Cellular Component of the Immune System in the Pathogenesis of Unconventional Slow Virus Infections
31. Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease
32. Early Identification of Variant Creutzfeldt-Jakob Disease: Some Promising Approaches but No Clear Answers Yet
33. Iatrogenic creutzfeldt-jakob disease, final assessment
34. Assessing prion infectivity of human urine in sporadic Creutzfeldt-Jakob disease
35. A Test for Creutzfeldt–Jakob Disease Using Nasal Brushings
36. Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification
37. Management and prevention of human prion diseases
38. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
39. Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in “spiked” human blood and red blood cells
40. Gerstmann-Sträussler-Scheinker Syndrome with Variable Phenotype in a New Kindred with PRNP-P102L Mutation
41. Neuroinvasion of the 263K scrapie strain after intranasal administration occurs through olfactory-unrelated pathways
42. Human Prion Diseases
43. Diagnostic accuracy of prion disease biomarkers in iatrogenic Creutzfeldt-Jakob disease
44. Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
45. Genetic prion disease: the EUROCJD experience
46. Ring trial of 2nd generation RT‐QuIC diagnostic tests for sporadic CJD
47. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease
48. Role of proteomics in understanding prion infection
49. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
50. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in “spiked” albumin solutions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.